Voting common shares
- Symbol
- DMAC
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
DiaMedica Therapeutics Inc.
DMACNASDAQEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On August 10, 2026, DiaMedica Therapeutics Inc. (the “Company”) announced its condensed consolidated financial results for the quarter ended June 30, 2026.…
Press release in this filing
DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights →Company context
Current securities
Historical securities (1)
Registered securities in this filing
DIAMEDICA THERAPEUTICS INC. · 8-K · Filed 2026-08-10
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02.
Results of Operations and Financial Condition.
On August 10, 2026, DiaMedica Therapeutics Inc. (the “Company”) announced its condensed consolidated financial results for the quarter ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and the information set forth therein is incorporated herein by reference and constitutes a part of Item 2.02 of this report.
The information contained in Item 2.02 of this report and Exhibit 99.1 to this report shall not be deemed to be “filed” with the United States Securities and Exchange Commission for purposes of Section 18 of the United States Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be incorporated by reference into any filings made by the Company under the United States Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.